Physician profile
Louis Mazzella
NPI 1508029323
$5,269.94
in general payments reported to CMS, 2019-2025
6 companies · $576 in 2025
The $576 reported for 2025 was more than what 86% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $648 · 2020: $365 · 2021: $465 · 2022: $367 · 2023: $449 · 2024: $2,399 · 2025: $576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,051 · Travel and Lodging: $1,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,051.20 |
| Travel and Lodging | $1,373.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $4,732.96 | 2019-2025 | Acticoat 4" X 4", Versajet, Oasis |
| Cipher Pharmaceuticals US LLC | $194.11 | 2025 | Natroba, Spinosad |
| Solventum Corporation | $133.07 | 2025 | Activ.A.C. |
| Kerecis Limited | $113.98 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $83.23 | 2025 | Puraply Wound Matrix |
| Avanir Pharmaceuticals, INC. | $12.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Mazzella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.